285 related articles for article (PubMed ID: 11177695)
21. Wilson disease.
El-Youssef M
Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
[TBL] [Abstract][Full Text] [Related]
22. Wilson's disease--treatment of psychiatric manifestations in pregnancy.
Rich AM; Lajoie TM
Psychosomatics; 2012; 53(2):175-7. PubMed ID: 22424165
[No Abstract] [Full Text] [Related]
23. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
Brewer GJ; Askari F; Dick RB; Sitterly J; Fink JK; Carlson M; Kluin KJ; Lorincz MT
Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
[TBL] [Abstract][Full Text] [Related]
24. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Merle U; Schaefer M; Ferenci P; Stremmel W
Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Wilson's disease.
Deiss A
Ann Intern Med; 1983 Sep; 99(3):398-400. PubMed ID: 6614689
[No Abstract] [Full Text] [Related]
26. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
Yarze JC
Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
[No Abstract] [Full Text] [Related]
27. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
Askari FK; Greenson J; Dick RD; Johnson VD; Brewer GJ
J Lab Clin Med; 2003 Dec; 142(6):385-90. PubMed ID: 14713890
[TBL] [Abstract][Full Text] [Related]
28. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
29. The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease.
Asatoor AM; Milne MD; Walshe JM
J R Coll Physicians Lond; 1983 Apr; 17(2):122-5. PubMed ID: 6842414
[TBL] [Abstract][Full Text] [Related]
30. [Wilsons disease].
Mareček Z; Brůha R
Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
[TBL] [Abstract][Full Text] [Related]
31. Combination treatment with penicillamine and trientine in a patient with Wilson's disease.
Kobayashi S; Kodama H; Inuzuka R; Mori Y; Yanagawa Y
Pediatr Int; 2005 Oct; 47(5):589-91. PubMed ID: 16190972
[No Abstract] [Full Text] [Related]
32. Wilson's disease: current status.
Yarze JC; Martin P; Muñoz SJ; Friedman LS
Am J Med; 1992 Jun; 92(6):643-54. PubMed ID: 1605146
[TBL] [Abstract][Full Text] [Related]
33. [Pregnancy in a patient treated with trientine dihydrochloride for Wilson's disease].
Desbriere R; Roquelaure B; Sarles J; Boubli L
Presse Med; 1998 May 2-9; 27(17):806. PubMed ID: 9767885
[No Abstract] [Full Text] [Related]
34. Trientine-induced neurological deterioration in a patient with Wilson's disease.
Kim B; Chung SJ; Shin HW
J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
[TBL] [Abstract][Full Text] [Related]
35. Wilson's disease.
Walshe JM
Lancet; 2007 Mar; 369(9565):902. PubMed ID: 17368141
[No Abstract] [Full Text] [Related]
36. [A study of trientine therapy in Wilson's disease with neurological symptoms].
Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
[TBL] [Abstract][Full Text] [Related]
37. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Walshe JM
QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
[TBL] [Abstract][Full Text] [Related]
38. Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.
Jacquelet E; Poujois A; Pheulpin MC; Demain A; Tinant N; Gastellier N; Woimant F
J Inherit Metab Dis; 2021 Nov; 44(6):1481-1488. PubMed ID: 34480375
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
Walshe JM
Lancet; 1982 Mar; 1(8273):643-7. PubMed ID: 6121964
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Dathe K; Beck E; Schaefer C
Reprod Toxicol; 2016 Oct; 65():39-45. PubMed ID: 27350316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
